AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026Business Wire • 01/12/26
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA PlatformZacks Investment Research • 12/12/25
AtriCure Announces the First Patients Treated with Novel Dual Energy PlatformBusiness Wire • 12/11/25
Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to TradeZacks Investment Research • 11/25/25
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare ConferenceBusiness Wire • 11/18/25
AtriCure, Inc. (ATRC) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/10/25
AtriCure (ATRC) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 11/07/25
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings (Revised)Zacks Investment Research • 11/06/25
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 EarningsZacks Investment Research • 10/29/25
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025Business Wire • 10/29/25
AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following AmputationBusiness Wire • 09/09/25